Croda International
OTCMKTS:COIHYCroda International Plc engages in the consumer care, life science, and industrial specialty businesses in in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers speciality and active ingredients across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, adjuvant systems, small molecule, protein, and nucleic acid delivery platforms, as well as purity materials for pharmaceutical formulations. In addition, the company offers crop protection and seed enhancement related solutions. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
Haier Electronics Group
OTCMKTS:HRELYAs of December 21, 2020, operates as a subsidiary of Haier Smart Home Co., Ltd.
Keppel
OTCMKTS:KPELYKeppel Ltd., an investment holding company, engages in the energy and environment, urban development, connectivity, and asset management businesses in Singapore, China, Hong Kong, Brazil, other far East and ASEAN countries, and internationally. It constructs, fabricates, and repairs offshore production facilities and drilling rigs, power barges, specialized vessels, and other offshore production facilities; engineers, constructs, and fabricates platforms for the oil and gas sector; undertakes shipyard works and other general business activities; procures equipment and materials for the construction of offshore production facilities; produces jacking systems; and operates food hubs. The company also sources, fabricates, and supplies steel components; owns ships; invests in and manages properties; operates golf clubs; owns and operates hotels; develops residential and commercial properties; develops district heating and cooling systems; generates and supplies power; purchases and sells gaseous fuels; retails telecommunication equipment and accessories; and designs and constructs waste-to-energy plants. In addition, it engages in the ship repairing, shipbuilding, and conversion activities; chartering of ships, barges, and boats with the crew; general wholesale and oilfield equipment trading activities; and development and operation of data centers. Further, the company offers fixed and other telecommunication, fund management, project management and procurement, financial, real estate investment trust management, logistics, warehousing, investment advisory, offshore and marine-related, supply chain, and environmental infrastructure and solid waste treatment services, as well as heavy-lift equipment and related services. The company was formerly known as Keppel Corporation and changed its name to Keppel Ltd. in January 2024. Keppel Ltd. Limited was incorporated in 1968 and is based in Singapore.
Nitto Denko
OTCMKTS:NDEKYNitto Denko Corporation primarily engages in the adhesive tapes business in Japan, the Americas, Europe, Asia, and Oceania. It provides double sided tapes, surface protective films, sealing materials, masking tapes, membranes, FPD/touch panel related products, gasket materials, semiconductor manufacturing process products, flexible printed circuit boards, porous films/breathable materials, and packaging tapes. The company also offers functional thermal transfer systems, such as labels, barcode label printers, and label printing software; tapes for electrical and electronic equipment; dust removal products for clean rooms; fluoroplastic sheets and tapes, and fluoroplastic porous films; and materials for housing and construction. In addition, it provides medical products, including transdermal therapeutic systems, athletic tapes, medical adhesive tapes for wearable devices and body sensors, adhesive tapes, and particles for nucleic acid synthesis. The company offers its products to automotive and transportation, housing/housing equipment, infrastructure, material, home appliance and electrical, display, electronic device, medical, packaging, and consumer/personal care industries. Nitto Denko Corporation was incorporated in 1918 and is headquartered in Osaka, Japan.
Recordati Industria Chimica e Farmaceutica
OTCMKTS:RCDTFRecordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.